v3.25.4
EQUITY OF AMERICAN ASSETS TRUST, INC.
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
EQUITY OF AMERICAN ASSETS TRUST, INC. EQUITY OF AMERICAN ASSETS TRUST, INC.
Stockholders' Equity

On December 3, 2021, we entered into an ATM equity program with five sales agents pursuant to which we may, from time to time, offer and sell shares of our common stock having an aggregate offering price of up to $250 million. The sale of shares of our common stock made through the ATM equity program, as amended, are made in “at-the-market” offerings as defined in Rule 415 of the Securities Act of 1933, as amended. For the year ended December 31, 2025, no shares of common stock were sold through the ATM equity program.

We intend to use the net proceeds from the ATM equity program to fund our development or redevelopment activities, repay amounts outstanding from time to time under our revolving line of credit or other debt financing obligations, fund potential acquisition opportunities and/or for general corporate purposes. As of December 31, 2025, we had the capacity to issue up to $250 million in shares of our common stock under our current ATM equity program. Actual future sales will depend on a variety of factors including, but not limited to, market conditions, the trading price of our common stock and our capital needs. As of December 31, 2025, we have no obligation to sell the remaining shares available for sale under the ATM equity program.
Preferred Stock Authorized Shares
We have been authorized to issue 10,000,000 shares of preferred stock with a par value of $0.01, of which no shares were outstanding at December 31, 2025. Upon issuance, our board of directors has the ability to define the terms of the preferred shares, including voting rights, liquidation preferences, conversion and redemption provisions and dividend rates. 
Dividends
The following table lists the dividends declared and paid on our shares of common stock and Noncontrolling Common Units for the years ended December 31, 2025, 2024 and 2023:
PeriodAmount per Share/UnitPeriod CoveredDividend Paid Date
First Quarter 2023$0.330 January 1, 2023 to March 31, 2023March 23, 2023
Second Quarter 2023$0.330 April 1, 2023 to June 30, 2023June 22, 2023
Third Quarter 2023$0.330 July 1, 2023 to September 30, 2023September 21, 2023
Fourth Quarter 2023$0.330 October 1, 2023 to December 31, 2023December 21, 2023
First Quarter 2024$0.335 January 1, 2024 to March 31, 2024March 21, 2024
Second Quarter 2024$0.335 April 1, 2024 to June 30, 2024June 20, 2024
Third Quarter 2024$0.335 July 1, 2024 to September 30, 2024September 19, 2024
Fourth Quarter 2024$0.335 October 1, 2024 to December 31, 2024December 19, 2024
First Quarter 2025$0.340 January 1, 2025 to March 31, 2025March 20, 2025
Second Quarter 2025$0.340 April 1, 2025 to June 30, 2025June 18, 2025
Third Quarter 2025$0.340 July 1, 2025 to September 30, 2025September 18, 2025
Fourth Quarter 2025$0.340 October 1, 2025 to December 31, 2025December 18, 2025
Taxability of Dividends
Earnings and profits, which determine the taxability of distributions to stockholders and holders of common units, may differ from income reported for financial reporting purposes due to the differences for federal income tax purposes in the treatment of loss on extinguishment of debt, revenue recognition and compensation expense and in the basis of depreciable assets and estimated useful lives used to compute depreciation. A summary of the income tax status of dividends per share paid is as follows:
Year Ended December 31,
202520242023
Per Share%Per Share%Per Share%
Ordinary income$0.56 41.3 %$1.09 81.5 %$1.20 90.6 %
Capital gain0.24 17.6 %— — %— — %
Return of capital0.56 41.1 %0.25 18.5 %0.12 9.4 %
Total$1.36 100.0 %$1.34 100.0 %$1.32 100.0 %
Stock-Based Compensation
The company has established the 2011 Equity Incentive Award Plan, which provides for grants to directors, employees and consultants of the company and the Operating Partnership of stock options, restricted stock, dividend equivalents, stock payments, performance shares, LTIP units, stock appreciation rights and other incentive awards. In June 2020, at the annual shareholder meeting, the shareholders approved the Amended and Restated 2011 Equity Incentive Award Plan (the “Amended and Restated 2011 Plan”). An aggregate of 4,054,411 shares of our common stock are authorized for issuance under awards granted pursuant to the Amended and Restated 2011 Plan, and as of December 31, 2025, 1,296,829 shares of common stock remain available for future issuance.
The following shares of restricted common stock have been issued as of December 31, 2025:
GrantFair Value at Grant DateNumber
June 5, 2023 (1)
19.3310,348 
December 7, 2023 (2)
14.65 - 15.54
290,541 
June 3, 2024 (1)
21.799,180 
December 4, 2024 (3)
19.83 - 20.79
236,052 
December 4, 2024 (4)
28.4758,416 
June 2, 2025 (1)
20.2117,812 
December 3, 2025 (5)
13.36 - 14.32
384,923 
(1)     Restricted common stock issued to members of the company's non-employee directors. These awards of restricted stock will vest subject to the director's continued service on the Board of Directors on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the next annual meeting of our stockholders, if such non-employee director continues his or her service on the Board of Directors until the next annual meeting of stockholders, but not thereafter, pursuant to our independent director compensation policy.
(2)    Restricted common stock issued to certain of the company's senior management and other employees, which are subject to quantitative and qualitative performance criteria based vesting. Up to one-third of the shares of restricted stock may vest based on such performance criteria determined as of November 30, 2024, 2025 and 2026, subject to the employee's continued employment on those dates.
(3)    Restricted common stock issued to certain of the company's senior management and other employees, which are subject to quantitative and qualitative performance criteria based vesting. Up to one-third of the shares of restricted stock may vest based on such performance criteria determined as of November 30, 2025, 2026 and 2027, subject to the employee's continued employment on those dates.
(4)    Time-based restricted common stock issued to Mr. Wyll related to his transition to Chief Executive Officer, which are eligible to vest in substantially equal one-third tranches on December 4, 2025, December 4, 2026 and December 4, 2027, subject to Mr. Wyll's continued employment on those dates.
(5)    Restricted common stock issued to certain of the company's senior management and other employees, which are subject to quantitative and qualitative performance criteria based vesting. Up to one-third of the shares of restricted stock may vest based on such performance criteria determined as of November 30, 2026, 2027 and 2028, subject to the employee's continued employment on those dates.
For the 2023, 2024, and 2025 grants, the fair value of the awards was estimated using a Monte Carlo Simulation model. For the 2023, 2024, and 2025 grants, vesting is subject to multiple vesting conditions as follows: (1) a service condition which requires continued employment of the employee as of each vesting date during the three-year vesting term for the employee to be eligible for vesting, (2) a performance condition with respect to our FFO per share for the FFO performance periods and (3) a market condition with respect to our relative total shareholder return performance over a one-year, two-year and three-year performance as compared to a pre-determined index. On each measurement date the performance condition and market condition performance will determine the number of shares that vest. We measure stock-based compensation expense based on the fair value of the award on the grant date, adjusted for changes to probabilities of achieving performance targets, and recognize expense over the vesting period. For the restricted stock grants that are time-vesting, issued to our non-employee directors, we estimate the stock compensation expense based on the fair value of the stock at the grant date.
The following table summarizes the activity of non-vested restricted stock awards during the year ended December 31, 2025:
2025
UnitsWeighted Average Grant Date Fair Value
Balance at beginning of year600,938 $19.40 
Granted402,735 14.13 
Vested(283,155)22.60 
Forfeited(27,261)18.42 
Balance at end of year693,257 $16.58 
We recognize noncash compensation expense ratably over the vesting period, and accordingly, we recognized $7.4 million, $7.1 million and $8.8 million in noncash compensation expense for the years ended December 31, 2025, 2024 and 2023, respectively, each of which is included in general and administrative expense on the statement of comprehensive income. Unrecognized compensation expense was $9.3 million at December 31, 2025, which will be recognized over a weighted-average period of 1.56 years.
Earnings Per Share
We have calculated earnings per share (“EPS”) under the two-class method. The two-class method is an earnings allocation methodology whereby EPS for each class of common stock and participating security is calculated according to dividends declared and participation rights in undistributed earnings. For the years ended December 31, 2025, 2024 and 2023, we had a weighted average of approximately 609,312 shares, 583,512 shares and 573,344 unvested shares outstanding, respectively, which are considered participating securities. Therefore, we have allocated our earnings for basic and diluted EPS between common shares and unvested shares.
Diluted EPS is calculated by dividing the net income attributable to common stockholders for the period by the weighted average number of common and dilutive instruments outstanding during the period using the treasury stock method. For the year ended December 31, 2025, diluted shares exclude incentive restricted stock as these awards are considered contingently issuable. Additionally, the unvested restricted stock awards subject to time vesting are anti-dilutive for all periods presented and accordingly, have been excluded from the weighted average common shares used to compute diluted EPS.
 
Earnings Per Unit of the Operating Partnership
Basic earnings per unit (“EPU”) of the Operating Partnership is computed by dividing income (loss) applicable to unitholders by the weighted average Operating Partnership units outstanding, as adjusted for the effect of participating securities. Operating Partnership units granted in equity-based payment transactions are considered participating securities prior to vesting. The impact of unvested Operating Partnership unit awards on EPU has been calculated using the two-class method whereby earnings are allocated to the unvested Operating Partnership unit awards based on distributions and the unvested Operating Partnership units’ participation rights in undistributed earnings (losses).
The calculation of diluted EPU for the year ended December 31, 2025, 2024 and 2023 does not include 609,312, 583,512, and 573,344 unvested weighted average Operating Partnership units, respectively, as these equity securities are either considered contingently issuable or the effect of including these equity securities was anti-dilutive to income from continuing operations and net income attributable to the unitholders.
The computation of basic and diluted EPS for American Assets Trust, Inc. is presented below (dollars in thousands, except share and per share amounts):
Year Ended December 31,
202520242023
NUMERATOR
Net income$71,370 $72,819 $64,690 
Less: Net income attributable to restricted shares(852)(787)(761)
Less: Income attributable to unitholders in the Operating Partnership
(14,870)(15,234)(13,551)
Net income attributable to common stockholders—basic
$55,648 $56,798 $50,378 
Income attributable to American Assets Trust, Inc. common stockholders—basic
$55,648 $56,798 $50,378 
Plus: Income attributable to unitholders in the Operating Partnership
14,870 15,234 13,551 
Net income attributable to common stockholders—diluted
$70,518 $72,032 $63,929 
DENOMINATOR
Weighted average common shares outstanding—basic
60,555,010 60,333,055 60,158,976 
Effect of dilutive securities—conversion of Operating Partnership units
16,181,537 16,181,537 16,181,537 
Weighted average common shares outstanding—diluted
76,736,547 76,514,592 76,340,513 
Earnings per common share, basic$0.92 $0.94 $0.84 
Earnings per common share, diluted$0.92 $0.94 $0.84